School of Exercise and Sport Science (University of Sydney)

Ms Rhonda Orr (Sport Pharmacology, Exercise & Aging)
Lecturer
Sport pharmacology, exercise scientist, strength training and elderly, pharmacist.
Rhonda Orr has had 13 years of experience in researching and teaching. Research has focussed on drugs in sport and athletes as well as exercise, functional performance and nutrition in older adults. With an extensive Postgraduate and Undergraduate teaching profile, she was part of the steering committee to develop the Bachelor of Applied Science (Exercise and Sport Science) and has developed the unique subject Sport Pharmacology which has been internationally recognised. She co-ordinates a High Schools Fitness Testing program and has given presentations and conducted workshops for health professionals and community workers in aged care, for Sports Medicine Australia and the NSW Police Force. She is regularly consulted by print, broadcast and visual media on issues primarily related to drugs in sport. She has a Level 1 Coaching Certificate and has coached young athletes, and has been a registered pharmacist for 28 years.

School of Chemistry (University of Sydney)

Prof Peter Lay (Dietary Supplements, Anti-Inflam.Drugs)
ARC Professorial Fellow & Personal Chair in Inorganic Chemistry.
Prof Lay works in the field of Chromuim dietary supplements, investigating benefits/risks. He is also active in developing non-steroidal anti-inflammatory drugs. These will be offered initially in the horse/camel market, although human trials are about to commence.

Dr Adrian George (Sport Drug Testing)
Director, First Year Studies
Performed research study in developing methods for detection of prohibited steroids for athletes (specifically, Dehydroepiandrosterone (DHEA), a naturally produced androgen) in collaboration with the Australian Sport Drug Testing Laboratory Biomedical Engineering Group.

Dr Malcolm Mcleod (Sport Drug Testing)
Senior Lecturer
Works with Adrian George in area of drug and drug metabolite analysis. Developing detection methods for prohibited steroids.

Dr Rachel Codd (Dietary Supplements)
BVR Lecturer in Bioinorganic Chemistry
Works with Peter Lay in area of dietary supplements (particularly Chromium based AccessGrid Project Manager at ViSLAB.

ANZAC Research Institute (University of Sydney)

Prof David Handelsman (Sports Anti-Doping)
Director
My group has extensive sports anti-doping and related pharmacology interests including being only academic researcher on Commonwealth's Antidoping Research Panel plus first papers on THG as a designer androgen.

Institute for Immunology and Allergy Research (University of Sydney)

Dr Connie Katelaris (Allergens)
Clinical Senior Lecturer
Dr Katelaris' team has been monitoring airborn pollens at each of the Olympic sites since 1993 for assistance to all national teams and as an extension of her research interest in the effects of allergic symptoms on elite athletes. These studies have been carried out in collaboration with the Australian Institute of Sport.

Herbal Medicine Research & Education Centre (University of Sydney)

Dr George Li (Herbal & Complementary Medicines)
Coordinator, Academic (Research)
Dr Li is interested in the efficacy and safety of complementary medicines in sport.
His primary research fields include:

• Mechanism of action and active components of popular herbal    medicines for management of diabetics.

• Immunomodulation and active components of popular herbal    medicines for cancer management.

• Pharmacognosy standardization, characterization, quantitative    analysis of herbal medicines such as Echinacea, and propolis    with HPTLC and HPLC

Faculty of Pharmacy (University of Sydney)

Dr Andrew McLachlan (Variability In Drug Responses)
Senior Lecturer
Dr McLachlan is active in the area of drugs and sports. His research aims to investigate the factors that influence variability in drug response through a sound understanding of drug disposition and action. His research portfolio can be divided into two broad categories namely; (a) clinical and (b) experimental aspects of drug disposition and action. The research hypothesis is that by understanding and characterising the factors that influence variability in pharmacokinetics and pharmacodynamics we can improve patient outcome. The key research strategies involve investigation of drug elimination, drug distribution, drug interactions, pharmacogenetics and the impact of age and disease on pharmacokinetics.